Liquidia (LQDA) Other Operating Expenses (2020 - 2026)
Liquidia (LQDA) posted Other Operating Expenses of $11.5 million for Q2 2026, down 2.55% on a QoQ basis from $11.9 million in Q1 2026, and up 671.54% year-over-year from $1.5 million in Q2 2025.
Analysis
Liquidia (LQDA) Other Operating Expenses (2020 - 2026) Analysis & Trends
Liquidia has reported Other Operating Expenses for 7 years, with the latest figure at $11.5 million in Q2 2026.
- On a quarterly basis, Other Operating Expenses rose 671.54% year-over-year to $11.5 million in Q2 2026; TTM through Jun 2026 was $33.6 million, a 466.83% increase from a year earlier, with the FY2025 full-year figure at $13.2 million, up 125.24% from the prior year.
- Other Operating Expenses was $11.5 million for Q2 2026 at Liquidia, down from $11.9 million in the prior quarter.
- The five-year high for Other Operating Expenses was $11.9 million in Q1 2026, with the low at $570000.0 in Q3 2023.
- Average Other Operating Expenses over 5 years is $2.7 million, with a median of $1.4 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Other Operating Expenses fell 22.97% in 2023, then soared 681.28% in 2026.
- Over 5 years, Other Operating Expenses stood at $694000.0 in 2022, then jumped by 43.08% to $993000.0 in 2023, then surged by 36.35% to $1.4 million in 2024, then surged by 421.05% to $7.1 million in 2025, then surged by 63.71% to $11.5 million in 2026.
- The last three Other Operating Expenses figures came in at $11.5 million (Q2 2026), $11.9 million (Q1 2026), and $7.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | Liquidia | 6.09 Bn | 5.81 Bn | 160.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.55 Mn |
| Mar 31, 2026 | 11.85 Mn |
| Dec 31, 2025 | 7.06 Mn |
| Sep 30, 2025 | 3.17 Mn |
| Jun 30, 2025 | 1.50 Mn |
| Mar 31, 2025 | 1.52 Mn |
| Dec 31, 2024 | 1.35 Mn |
| Sep 30, 2024 | 1.57 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 993,000.00 |
| Sep 30, 2023 | 570,000.00 |
| Jun 30, 2023 | 671,000.00 |
| Mar 31, 2023 | 654,000.00 |
| Dec 31, 2022 | 694,000.00 |
| Sep 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 731,000.00 |
| Mar 31, 2022 | 694,000.00 |
| Dec 31, 2021 | 726,000.00 |
| Sep 30, 2021 | 890,000.00 |